Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial.
Di Pierro F, Khan A, Iqtadar S, Mumtaz SU, Chaudhry MNA, Bertuccioli A, Derosa G, Maffioli P, Togni S, Riva A, Allegrini P, Recchia M, Zerbinati N.
Di Pierro F, et al. Among authors: chaudhry mna.
Front Pharmacol. 2023 Jan 13;13:1096853. doi: 10.3389/fphar.2022.1096853. eCollection 2022.
Front Pharmacol. 2023.
PMID: 36712674
Free PMC article.